ATE371868T1 - Verfahren zur charakterisierung von zellen in suspension - Google Patents

Verfahren zur charakterisierung von zellen in suspension

Info

Publication number
ATE371868T1
ATE371868T1 AT97949270T AT97949270T ATE371868T1 AT E371868 T1 ATE371868 T1 AT E371868T1 AT 97949270 T AT97949270 T AT 97949270T AT 97949270 T AT97949270 T AT 97949270T AT E371868 T1 ATE371868 T1 AT E371868T1
Authority
AT
Austria
Prior art keywords
target cells
suspension
cell suspensions
particles
characterizing cells
Prior art date
Application number
AT97949270T
Other languages
English (en)
Inventor
Oystein Fodstad
Hanne Hoifodt
Original Assignee
Oystein Fodstad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oystein Fodstad filed Critical Oystein Fodstad
Application granted granted Critical
Publication of ATE371868T1 publication Critical patent/ATE371868T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT97949270T 1996-12-20 1997-12-16 Verfahren zur charakterisierung von zellen in suspension ATE371868T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO965531A NO308755B1 (no) 1996-12-20 1996-12-20 FremgangsmÕte til karakterisering av unormale celler, anvendelse og sett for utførelse av fremgangsmÕten

Publications (1)

Publication Number Publication Date
ATE371868T1 true ATE371868T1 (de) 2007-09-15

Family

ID=19900214

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97949270T ATE371868T1 (de) 1996-12-20 1997-12-16 Verfahren zur charakterisierung von zellen in suspension

Country Status (9)

Country Link
US (1) US8097429B2 (de)
EP (1) EP0951645B1 (de)
AT (1) ATE371868T1 (de)
AU (1) AU728190B2 (de)
CA (1) CA2275335C (de)
DE (1) DE69738076T2 (de)
ES (1) ES2293663T3 (de)
NO (1) NO308755B1 (de)
WO (1) WO1998028622A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6642062B2 (en) * 1998-09-03 2003-11-04 Trellis Bioinformatics, Inc. Multihued labels
US6828157B1 (en) 1999-05-04 2004-12-07 Dan A. Pankowsky Products and methods for single parameter and multiparameter phenotyping of cells
US6682940B2 (en) 1999-05-04 2004-01-27 Dan A. Pankowsky Products and methods for single parameter and multiparameter phenotyping of cells
GB9913556D0 (en) * 1999-06-11 1999-08-11 Zeneca Ltd Assays
AU2002214689A1 (en) * 2000-11-06 2002-05-15 Bio-Tech Imaging, Inc. Method and kits for detecting hepatitis infected cells
US20030190602A1 (en) * 2001-03-12 2003-10-09 Monogen, Inc. Cell-based detection and differentiation of disease states
KR20030094281A (ko) * 2001-03-12 2003-12-11 모노젠, 인크. 세포에 기초한 질병상태의 검출 및 질병상태의 구별
CA2445611A1 (en) * 2001-05-31 2002-12-05 Chiron Corporation P-cadherin as a target for anti-cancer therapy
EP1474772A4 (de) * 2002-02-14 2005-11-09 Immunivest Corp Verfahren und algorithmen zur zellenaufzählung in einem kostengünstigen zytometer
TW200521433A (en) * 2003-12-22 2005-07-01 We Gene Technologies Inc Cell detection chip and fabricating method thereof and method of detecting cell
US8189899B2 (en) 2004-07-30 2012-05-29 Veridex, Llc Methods and algorithms for cell enumeration in a low-cost cytometer
SE0402536D0 (sv) * 2004-10-20 2004-10-20 Therim Diagnostica Ab Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US8372584B2 (en) 2006-06-14 2013-02-12 The General Hospital Corporation Rare cell analysis using sample splitting and DNA tags
WO2007147074A2 (en) 2006-06-14 2007-12-21 Living Microsystems, Inc. Use of highly parallel snp genotyping for fetal diagnosis
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
HUE028487T2 (en) * 2007-02-27 2016-12-28 Sentoclone Int Ab Detection of tumor cell multiplex using panel of agents associated with extracellular markers
KR20120087885A (ko) * 2007-06-29 2012-08-07 안국약품 주식회사 난소암의 예측 마커
PT2334812T (pt) 2008-09-20 2017-03-29 Univ Leland Stanford Junior ¿diagnóstico não invasivo de aneuploidia fetal por sequenciação
CN102432685A (zh) * 2011-11-01 2012-05-02 中国环境科学研究院 检测重组小鼠碱性成纤维细胞生长因子的免疫胶乳微球及其制备方法和应用
JP6310861B2 (ja) * 2012-12-26 2018-04-11 原　正則 尿中ポドサイトの検出方法
DE102013106432A1 (de) * 2013-06-20 2014-12-24 Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH + Co. KG Optische Indikator-Einheit und Vorrichtung und Verfahren zur Bestimmung einer physikalisch-chemischen Eigenschaft eines Prozessmediums in einer prozesstechnischen Anlage
WO2016164467A1 (en) * 2015-04-06 2016-10-13 University Of Miami Imaging device and method for detection of disease

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4511662A (en) * 1982-06-18 1985-04-16 Bio-Rad Laboratories, Inc. Simultaneous assay for T and B lymphocyte populations and subpopulations
JPH07104349B2 (ja) * 1987-04-11 1995-11-13 株式会社日立製作所 細胞測定法
US5194300A (en) * 1987-07-15 1993-03-16 Cheung Sau W Methods of making fluorescent microspheres
FR2638849B1 (fr) * 1988-11-04 1994-03-18 Chemunex Sa Procede d'amplification d'un signal fluorescent pour la recherche specifique de la presence eventuelle de particules et application a la detection et a la numeration desdites particules
FR2638848B1 (fr) * 1988-11-04 1993-01-22 Chemunex Sa Procede de detection et/ou de dosage dans un milieu liquide ou semi-liquide d'au moins une substance organique, biologique ou medicamenteuse soluble, par une methode d'agglutination
US5340719A (en) * 1990-11-23 1994-08-23 Corporation Coulter Method and apparatus for optically screening microscopic cells
AU2115092A (en) * 1991-10-08 1993-04-22 Eastman Kodak Company Method, test device and kit for assay of specific binding ligand using controlled flow through filtration membrane
US5290707A (en) * 1991-11-25 1994-03-01 The United States Of America As Represented By The Secretary Of The Army Method for detection of microorganisms
US5256542A (en) * 1992-03-09 1993-10-26 Tanox Biosystems, Inc. Selecting low frequency antigen-specific single B lymphocytes with correction for background noise
DK0660936T3 (da) * 1992-09-14 1999-05-25 Stanford Res Inst Int Op-konverterende reportermolekyle til biologiske og andre assays under anvendelse af laserexcitationsteknik
AU2593192A (en) * 1992-09-14 1994-04-12 Oystein Fodstad Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
US5374531A (en) * 1993-03-22 1994-12-20 Zynaxis, Inc. Immunoassay for determination of cells
AUPN214095A0 (en) * 1995-04-03 1995-04-27 Australian Water Technologies Pty Ltd Method for detecting microorganisms using flow cytometry

Also Published As

Publication number Publication date
DE69738076T2 (de) 2008-05-21
NO965531D0 (no) 1996-12-20
CA2275335A1 (en) 1998-07-02
US8097429B2 (en) 2012-01-17
EP0951645A1 (de) 1999-10-27
EP0951645B1 (de) 2007-08-29
NO308755B1 (no) 2000-10-23
WO1998028622A1 (en) 1998-07-02
ES2293663T3 (es) 2008-03-16
AU7875298A (en) 1998-07-17
CA2275335C (en) 2008-02-12
US20050130234A1 (en) 2005-06-16
AU728190B2 (en) 2001-01-04
DE69738076D1 (de) 2007-10-11
NO965531L (no) 1998-06-22

Similar Documents

Publication Publication Date Title
DE69738076D1 (de) Verfahren zur Charakterisierung von Zellen in Suspension
DE60019111D1 (de) Verfahren zur zellseparation unter verwendung von immunorosetten
ATE129347T1 (de) Biologisch aktive reagenzien aus carboxylgruppenhaltigen polymerisaten, analytisches element und verfahren zur verwendung.
DE3060928D1 (en) Method of magnetic separation of cells and the like, and microspheres for use therein
DE3869969D1 (de) Versuchsmethode unter verwendung von partikeln mit assoziiertem, fluoreszierendem stoff.
DE69816474D1 (de) Stabilisierte teilchen deren herstellung und anwendung
ATE501249T1 (de) Zusammensetzung und verfahren zur regulierung der adhäsion von zellen und biomolekülen an hydrophobe oberflächen
ATE251306T1 (de) Gerät und methoden zum einfnag und zur analyse von partikel-einheiten
MY100973A (en) Immuno- agglutination suspensions
DE3579059D1 (de) Apparat zur beschichtung von kernbrennstoffpartikeln mit einem brennbaren absorber.
ATE150871T1 (de) Verfahren zur herstellung von biologisch aktiven reagentien aus succinimid enthaltenden polymeren, analytisches element und verwendungsmethoden
MX9604183A (es) Metodo de examen para identificar ligandos para proteinas objetivo.
CA2093415A1 (en) Test method and reagent kit therefor
ATE177533T1 (de) Verfahren zur bestimmung einer immunologischen aktiven substanz mittels magnetischer latexteilchen und nichtmagnetischer teilchen
ATE397215T1 (de) Entstörung von immunoassays durch substanzen, die aus den framework-regionen von antikörpern abgeleitet sind
ATE297715T1 (de) Teilchen
AU3590384A (en) Automatic analysis of i.d. quantity and sorting of small particles
DE69018482D1 (de) Trennungsverfahren zum trennen von hämatopoeitischen vorläuferzellen.
NO172910C (no) Fremgangsmaate for utproeving av en proeve av celler med hensyn til naervaer av celleoverflateantigen
ATE53912T1 (de) Verfahren zur konzentrierung und bestimmung von biomolekuelen und zellen.
NZ515852A (en) Products and methods for single parameter and multiparameter phenotyping of cells
DE68913446D1 (de) Apparat zur Bestimmung von zwei Substanzen unter Verwendung von Enzymelektroden und Verfahren zur Ausführung dieser Bestimmung.
Hydén et al. Proteins S-100 and 14-3-2 in nerve cells of rats raised in enriched and impoverished environments: Distribution, quantification, and cell separation by surface antigens
ATE132896T1 (de) Methoden zur verwendung von an humanen klasse-ii- histokompatibilitätsantigenen mangelnden zellinien
FI843562A0 (fi) Foerfarande foer immunokemisk bestaemning av hepatitis b kaernantigener.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties